{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T21:22:52Z","timestamp":1782336172090,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/s10156-011-0288-0","type":"journal-article","created":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T09:15:06Z","timestamp":1313572506000},"page":"595-601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Widespread use of neuraminidase inhibitors in Japan"],"prefix":"10.1016","volume":"17","author":[{"given":"Norio","family":"Sugaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s10156-011-0288-0_bib0005","series-title":"Lower clinical effectiveness of oseltamivir against influenza B infection","author":"Sugaya","year":"2005"},{"key":"10.1007\/s10156-011-0288-0_bib0010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1086\/589748","article-title":"Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children","volume":"47","author":"Sugaya","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1007\/s10156-011-0288-0_bib0015","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1128\/JCM.00439-10","article-title":"Sensitivity of influenza rapid diagnostic tests to H5N1 and 2009 pandemic H1N1 viruses","volume":"48","author":"Sakai-Tagawa","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1007\/s10156-011-0288-0_bib0020","unstructured":"Ministry of Health, Welfare and Labour, Japan. Infectious Diseases Weekly Report Japan (IDWR). 2010;12:10\u20135. Available at http:\/\/idsc.nih.go.jp\/idwr\/kanja\/idwr\/idwr2010\/idwr2010-10.pdf"},{"issue":"1","key":"10.1007\/s10156-011-0288-0_bib0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1056\/NEJMoa0910444","article-title":"Severe 2009 H1N1 influenza in pregnant and postpartum women in California","volume":"362","author":"Louie","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1007\/s10156-011-0288-0_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2011.06.008","article-title":"Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: analysis of 1000 hospitalized children","author":"Sugaya","year":"2011","journal-title":"J Infect"},{"issue":"18","key":"10.1007\/s10156-011-0288-0_bib0035","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMra1000449","article-title":"Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection","volume":"362","author":"Bautista","year":"2010","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1007\/s10156-011-0288-0_bib0040","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1056\/NEJMoa0906695","article-title":"Hospitalized patients with 2009 H1N1 influenza in the United States, April\u2013June 2009","volume":"361","author":"Jain","year":"2009","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1007\/s10156-011-0288-0_bib0045","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.2009.1536","article-title":"Critically ill patients with 2009 influenza A (H1N1) in Mexico","volume":"302","author":"Dominguez-Cherit","year":"2009","journal-title":"JAMA"},{"issue":"3","key":"10.1007\/s10156-011-0288-0_bib0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1503\/cmaj.091884","article-title":"Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection","volume":"182","author":"Zarychanski","year":"2010","journal-title":"Can Med Assoc J"},{"issue":"9755","key":"10.1007\/s10156-011-0288-0_bib0055","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/S0140-6736(10)61195-6","article-title":"Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study","volume":"376","author":"Sachedina","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1007\/s10156-011-0288-0_bib0060","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1128\/AAC.01755-09","article-title":"Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection","volume":"54","author":"Sugaya","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1007\/s10156-011-0288-0_bib0065","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1086\/656802","article-title":"Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: a double-blind, randomized, noninferiority clinical trial","volume":"51","author":"Watanabe","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1007\/s10156-011-0288-0_bib0070","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1128\/AAC.01718-10","article-title":"Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients","volume":"55","author":"Kohno","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1007\/s10156-011-0288-0_bib0075","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.antiviral.2009.02.198","article-title":"T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections","volume":"82","author":"Furuta","year":"2009","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1007\/s10156-011-0288-0_bib0080","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1073\/pnas.0909603107","article-title":"T-705 (favipiravir) activity against lethal H5N1 influenza A viruses","volume":"107","author":"Kiso","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1007\/s10156-011-0288-0_bib0085","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/AAC.45.4.1162-1167.2001","article-title":"Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir","volume":"45","author":"Bantia","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1007\/s10156-011-0288-0_bib0090","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.antiviral.2006.10.004","article-title":"Susceptibility of highly pathogenic A (H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes","volume":"73","author":"Hurt","year":"2007","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1007\/s10156-011-0288-0_bib0095","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.antiviral.2008.05.012","article-title":"Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice","volume":"80","author":"Boltz","year":"2008","journal-title":"Antiviral Res"},{"issue":"11","key":"10.1007\/s10156-011-0288-0_bib0100","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1128\/AAC.00474-10","article-title":"Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection","volume":"54","author":"Kohno","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1007\/s10156-011-0288-0_bib0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2005.10.002","article-title":"Anti-influenza virus activity of peramivir in mice with single intramuscular injection","volume":"69","author":"Bantia","year":"2006","journal-title":"Antiviral Res"},{"issue":"11","key":"10.1007\/s10156-011-0288-0_bib0110","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1128\/AAC.49.11.4515-4520.2005","article-title":"Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors","volume":"49","author":"Mishin","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1007\/s10156-011-0288-0_bib0115","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1128\/AAC.00333-08","article-title":"CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity","volume":"53","author":"Yamashita","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1007\/s10156-011-0288-0_bib0120","doi-asserted-by":"crossref","first-page":"e1000786","DOI":"10.1371\/journal.ppat.1000786","article-title":"Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses","volume":"6","author":"Kiso","year":"2010","journal-title":"PLoS Pathog"},{"issue":"11","key":"10.1007\/s10156-011-0288-0_bib0125","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1177\/0091270009356297","article-title":"Clinical pharmacokinetics of laninamivir, a novel long-acting neuraminidase inhibitor, after single and multiple inhaled doses of its prodrug, CS-8958, in healthy male volunteers","volume":"50","author":"Ishizuka","year":"2010","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"10.1007\/s10156-011-0288-0_bib0130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/509925","article-title":"Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children","volume":"44","author":"Sugaya","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1007\/s10156-011-0288-0_bib0135","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/01.inf.0000059763.79081.9a","article-title":"Influenza A-associated central nervous system dysfunction in children presenting as transient visual hallucination","volume":"22","author":"Huang","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1007\/s10156-011-0288-0_bib0140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.braindev.2004.07.005","article-title":"Delirious behavior in children with influenza: its clinical features and EEG findings","volume":"27","author":"Okumura","year":"2005","journal-title":"Brain Dev"},{"key":"10.1007\/s10156-011-0288-0_bib0145","unstructured":"Ministry of Health, Labor and Welfare. Vital Statistics of Japan. Available at: http:\/\/www.e-stat.go.jp\/SG1\/estat\/GL08020101.do?_toGL08020101_&tstatCode=000001028897&requestSender=dsearch"},{"issue":"2","key":"10.1007\/s10156-011-0288-0_bib0150","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.legalmed.2007.07.003","article-title":"Analysis of oseltamivir active metabolite, oseltamivir carboxylate, in biological materials by HPLC-UV in a case of death following ingestion of Tamiflu","volume":"10","author":"Fuke","year":"2008","journal-title":"Leg Med (Tokyo)"},{"issue":"8","key":"10.1007\/s10156-011-0288-0_bib0155","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1086\/656408","article-title":"Early oseltamivir treatment of influenza in children 1\u20133 years of age: a randomized controlled trial","volume":"51","author":"Heinonen","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1007\/s10156-011-0288-0_bib0160","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00006454-200102000-00002","article-title":"Oral oseltamivir treatment of influenza in children","volume":"20","author":"Whitley","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1007\/s10156-011-0288-0_bib0165","doi-asserted-by":"crossref","first-page":"b3172","DOI":"10.1136\/bmj.b3172","article-title":"Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials","volume":"339","author":"Shun-Shin","year":"2009","journal-title":"BMJ"},{"key":"10.1007\/s10156-011-0288-0_bib0170","unstructured":"Ministry of Health, Welfare and Labour, Japan. Infectious Agents Surveillance Report (IASR). 2011. Available at: http:\/\/idsc.nih.go.jp\/iasr\/rapid\/pr3641.html"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X11704329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X11704329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10156-011-0288-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:47:55Z","timestamp":1761158875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X11704329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"alternative-id":["S1341321X11704329"],"URL":"https:\/\/doi.org\/10.1007\/s10156-011-0288-0","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Widespread use of neuraminidase inhibitors in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s10156-011-0288-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}